Cephalon's Frank Baldino - CEO Pay

Frank Baldino - Cephalon

Total Compensation: $14.5M

Details: In 2007, with an overall salary of $13.5 million, Baldino managed to pull down $2 million more than the previous year. The CEO--who's paid much more than those in his peer group--didn't manage such a hefty salary jump in 2008. With his total compensation rounding out to $14.5 million, Baldino's 2008 raise came in at just under $1 million last year. His salary included $63,750 for personal use of the company car, insurance, financial planning and medical reimbursements.

Cephalon News:
Cephalon hikes prices to fight generic
Cephalon finalizes $425M off-label settlement
FDA approves Cephalon's Treanda
FDA panel rejects broader Fentora use
FTC sues Cephalon for blocking generics
Cephalon, NitroMed make cuts jobs

Cephalon's Frank Baldino - CEO Pay
Read more on

Suggested Articles

New Gilead CEO Daniel O’Day has already replaced some key leaders at the company, but he’s not stopping there with the executive overhaul.

The FDA lambasted Strides Pharma in a warning letter after inspectors found testing records in the trash and in bags by a shredder.

If Seattle Genetics' second-quarter earnings report is any indication, the company's lead product is finally living up to its potential.